KCT0003578尚未招募未知
A Study on the Improvement of Physical Evaluation Method for Subjects with Lumbar Instability
Kaya university0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 40(Year) 至 67(Year)(—)
- 性别
- All
入选标准
- •The purpose of this study was to investigate patients with back pain who were admitted to J hangbang Hospital and diagnosed with anterior spondylolisthesis. The anterior translation of the vertebra was selected based on the degree of translation of more than 4 mm between the vertebral bodies and the sagittal plane angle of more than 10 ° between the lumbar spine and the lumbar spine. A total of 40 subjects were divided into two groups of 20 subjects each according to the method of the waist stabilization exercise. Supine bridge exercise group and Forward leaning exercise group will be divided into two groups.
排除标准
- •Those who have a lumbar lumbar spine and a range of joint motion that can not be leaned forward, and those with neurological and orthopedic disorders that cause other movement disorders such as tumors, spinal cord injuries, and infections will be excluded.
研究者
相似试验
已完成
不适用
Exploratory study on improvement of physical ability by voluntary training for type 2 diabetic patientsType 2 diabeticsJPRN-UMIN000039235niversity of Tsukuba Hospital30
已完成
不适用
A study of improvement effects on physical functions by ingesting a food ingredient.Elderly male/female subjectsJPRN-UMIN000047871CPCC Company Limited60
尚未招募
不适用
To assess repigmentation in patients with vitiligo using AVARI (Automated Vitiligo area Repigmentation Index)CTRI/2021/09/036800Dr Deepti Jaiswal
已完成
不适用
Evaluation of shunt physical examination by artificial intelligencechronic kidney diseaseJPRN-UMIN000041587Department of Nephrology, Gamagori City Hospital, Gamagori 443-8501, Japan220
招募中
不适用
Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Patients 1 Year of Age and Over with GSD III.Glycogen Storage Disease III10027424NL-OMON51818ltragenyx pharmaceutical Inc.2
